Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC.TO)

Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,512,500
  • Shares Outstanding, K 370,517
  • Annual Sales, $ 9,625 M
  • Annual Income, $ -46,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.69
  • Price/Sales 0.25
  • Price/Cash Flow 1.70
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 51.16% (+1.56%)
  • Historical Volatility 67.20%
  • IV Percentile 20%
  • IV Rank 12.91%
  • IV High 246.34% on 04/10/25
  • IV Low 22.24% on 08/14/25
  • Expected Move (DTE 3) 0.43 (4.60%)
  • Put/Call Vol Ratio 0.65
  • Today's Volume 433
  • Volume Avg (30-Day) 243
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 7,956
  • Open Int (30-Day) 7,050
  • Expected Range 9.00 to 9.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.71
  • Number of Estimates 3
  • High Estimate 1.89
  • Low Estimate 1.58
  • Prior Year 1.61
  • Growth Rate Est. (year over year) +6.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.35 +12.93%
on 11/20/25
10.52 -10.36%
on 12/04/25
+0.10 (+1.07%)
since 11/07/25
3-Month
8.20 +15.00%
on 10/29/25
10.52 -10.36%
on 12/04/25
-0.57 (-5.70%)
since 09/09/25
52-Week
5.91 +59.56%
on 04/11/25
12.07 -21.87%
on 12/10/24
-2.55 (-21.29%)
since 12/09/24

Most Recent Stories

More News
Stocks in play: Bausch Health Companies Inc.

Along with its global aesthetic business, Solta Medical, today announced the successful completion of ...

BHC.TO : 9.43 (-0.53%)
TSX Gains by Noon

Canada's main stock index inched upward by noon on Thursday, led by technology and materials sectors, ...

BHC.TO : 9.43 (-0.53%)
Bausch: Q3 Earnings Snapshot

Bausch: Q3 Earnings Snapshot

BHC.TO : 9.43 (-0.53%)
Stocks in play: Bausch Health Companies Inc.

Announced the results of the special meeting of shareholders held on October 7. At the Shareholders ...

BHC.TO : 9.43 (-0.53%)
Stocks in play: Bausch Health Companies Inc.

Will release third-quarter 2025 financial results after market close on Wednesday, October 29. Bausch ...

BHC.TO : 9.43 (-0.53%)
Central Bank Meetings Throw Scare into Investors

Canada's benchmark stock index fell on Tuesday, dragged down by gold mining and material shares, with ...

BHC.TO : 9.43 (-0.53%)
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline

DRRX : 1.9100 (-1.04%)
BHC.TO : 9.43 (-0.53%)
BHC : 6.80 (-0.29%)
TSX Hangs onto Gains

Stocks aped their American cousins Tuesday, with gains in the oil patch overcoming setbacks in industrial ...

BHC.TO : 9.43 (-0.53%)
Rate Cut Hope Buoys Stocks Tuesday

Equities in Toronto sprang up Tuesday to begin a short week, with much of the momentum coming from gold ...

BHC.TO : 9.43 (-0.53%)
Bausch: Q2 Earnings Snapshot

Bausch: Q2 Earnings Snapshot

BHC.TO : 9.43 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical;...

See More

Key Turning Points

3rd Resistance Point 9.90
2nd Resistance Point 9.72
1st Resistance Point 9.58
Last Price 9.43
1st Support Level 9.26
2nd Support Level 9.08
3rd Support Level 8.94

See More

52-Week High 12.07
Fibonacci 61.8% 9.72
Last Price 9.43
Fibonacci 50% 8.99
Fibonacci 38.2% 8.26
52-Week Low 5.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar